CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells

Nat Commun. 2021 Jul 22;12(1):4474. doi: 10.1038/s41467-021-24734-0.

Abstract

Non-alcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease that can progress to liver fibrosis. Recent clinical advance suggests a reversibility of liver fibrosis, but the cellular and molecular mechanisms underlying NASH resolution remain unclarified. Here, using a murine diet-induced NASH and the subsequent resolution model, we demonstrate direct roles of CD8+ tissue-resident memory CD8+ T (CD8+ Trm) cells in resolving liver fibrosis. Single-cell transcriptome analysis and FACS analysis revealed CD69+CD103-CD8+ Trm cell enrichment in NASH resolution livers. The reduction of liver CD8+ Trm cells, maintained by tissue IL-15, significantly delayed fibrosis resolution, while adoptive transfer of these cells protected mice from fibrosis progression. During resolution, CD8+ Trm cells attracted hepatic stellate cells (HSCs) in a CCR5-dependent manner, and predisposed activated HSCs to FasL-Fas-mediated apoptosis. Histological assessment of patients with NASH revealed CD69+CD8+ Trm abundance in fibrotic areas, further supporting their roles in humans. These results highlight the undefined role of liver CD8+ Trm in fibrosis resolution.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adoptive Transfer
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Apoptosis / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Hepatic Stellate Cells / immunology
  • Hepatic Stellate Cells / pathology*
  • Humans
  • Immunologic Memory
  • Interleukin-15 / immunology
  • Liver Cirrhosis / immunology*
  • Liver Cirrhosis / pathology*
  • Liver Cirrhosis / therapy
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / immunology*
  • Non-alcoholic Fatty Liver Disease / pathology*
  • Non-alcoholic Fatty Liver Disease / therapy
  • Receptors, CCR5 / immunology
  • Young Adult

Substances

  • CCR5 protein, mouse
  • Interleukin-15
  • Receptors, CCR5